Skip to content

Evaluation of changes in gastrointestinal lesions following low dose aspirin administration

Evaluation of changes in gastrointestinal lesions following low dose aspirin administration - Gastrointestinal lesions after low dose aspirin

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000001695
Enrollment
50
Registered
2009-02-09
Start date
2009-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastroduodenal ulcer, intestinal ulcer

Interventions

None listed

Sponsors

Kanto Medical Center, NTT EastKanto Medical Center, NTT East
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: those who start taking low dose aspirin

Exclusion criteria

Exclusion criteria: those who have taken aspirin within the last 2 months

Design outcomes

Primary

MeasureTime frame
Endoscopic gastrointestinal mucosal lesions before and 1m after initiation of low dose aspirin administration

Secondary

MeasureTime frame
Endoscopic gastrointestinal mucosal lesions 1y after initiation of low dose aspirin administration

Countries

Japan

Contacts

Public ContactNobuyuki Matsuhashi

Kanto Medical Center, NTT East Department of Gastroenterology

nmatuha-tky@umin.ac.jp03-3448-6245

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026